Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! study

A. Volkers; L. Wieske; K. van Dam; M. Steenhuis; E. Stalman; L. Kummer; Z. van Kempen; J. Killestein; S. Tas; L. Boekel; G. Wolbink; B. Takkenberg; P. Spuls; A. Bosma; B. Rutgers; J. Verschuuren; L. van Ouwerkerk; D. van der Woude; P. van Paassen; M. Busch; E. Brusse; D. Hijnen; A. ten Brinke; N. Verstegen; G. D'Haens; M. van Ham; T. Kuijpers; T. Rispens; M. Lowenberg; F. Eftimov

Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! study

A. Volkers
, L. Wieske
, K. van Dam
, M. Steenhuis
, E. Stalman
, L. Kummer
, Z. van Kempen
, J. Killestein
, S. Tas
, L. Boekel
, G. Wolbink
, B. Takkenberg
, P. Spuls
, A. Bosma
, B. Rutgers
, J. Verschuuren
, L. van Ouwerkerk
, D. van der Woude
, P. van Paassen
, M. Busch

E. Brusse, D. Hijnen, A. ten Brinke, N. Verstegen, G. D'Haens, M. van Ham, T. Kuijpers, T. Rispens, M. Lowenberg, F. Eftimov

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

2 Citations (Web of Science)

Original language	English
Pages (from-to)	I079-I079
Number of pages	1
Journal	Journal of Crohn's and Colitis
Volume	16
Publication status	Published - Jan 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Volkers, A., Wieske, L., van Dam, K., Steenhuis, M., Stalman, E., Kummer, L., van Kempen, Z., Killestein, J., Tas, S., Boekel, L., Wolbink, G., Takkenberg, B., Spuls, P., Bosma, A., Rutgers, B., Verschuuren, J., van Ouwerkerk, L., van der Woude, D., van Paassen, P., ... Eftimov, F. (2022). Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! study. Journal of Crohn's and Colitis, 16, I079-I079.

@article{9268c1bc95d84fac927a3a6b7709f569,

title = "Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! study",

author = "A. Volkers and L. Wieske and \{van Dam\}, K. and M. Steenhuis and E. Stalman and L. Kummer and \{van Kempen\}, Z. and J. Killestein and S. Tas and L. Boekel and G. Wolbink and B. Takkenberg and P. Spuls and A. Bosma and B. Rutgers and J. Verschuuren and \{van Ouwerkerk\}, L. and \{van der Woude\}, D. and \{van Paassen\}, P. and M. Busch and E. Brusse and D. Hijnen and \{ten Brinke\}, A. and N. Verstegen and G. D'Haens and \{van Ham\}, M. and T. Kuijpers and T. Rispens and M. Lowenberg and F. Eftimov",

year = "2022",

month = jan,

language = "English",

volume = "16",

pages = "I079--I079",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

}

Volkers, A, Wieske, L, van Dam, K, Steenhuis, M, Stalman, E, Kummer, L, van Kempen, Z, Killestein, J, Tas, S, Boekel, L, Wolbink, G, Takkenberg, B, Spuls, P, Bosma, A, Rutgers, B, Verschuuren, J, van Ouwerkerk, L, van der Woude, D, van Paassen, P, Busch, M, Brusse, E , Hijnen, D, ten Brinke, A, Verstegen, N, D'Haens, G, van Ham, M, Kuijpers, T, Rispens, T, Lowenberg, M & Eftimov, F 2022, 'Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! study', Journal of Crohn's and Colitis, vol. 16, pp. I079-I079.

Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! study. / Volkers, A.; Wieske, L.; van Dam, K. et al.
In: Journal of Crohn's and Colitis, Vol. 16, 01.2022, p. I079-I079.

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

TY - JOUR

T1 - Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! study

AU - Volkers, A.

AU - Wieske, L.

AU - van Dam, K.

AU - Steenhuis, M.

AU - Stalman, E.

AU - Kummer, L.

AU - van Kempen, Z.

AU - Killestein, J.

AU - Tas, S.

AU - Boekel, L.

AU - Wolbink, G.

AU - Takkenberg, B.

AU - Spuls, P.

AU - Bosma, A.

AU - Rutgers, B.

AU - Verschuuren, J.

AU - van Ouwerkerk, L.

AU - van der Woude, D.

AU - van Paassen, P.

AU - Busch, M.

AU - Brusse, E.

AU - Hijnen, D.

AU - ten Brinke, A.

AU - Verstegen, N.

AU - D'Haens, G.

AU - van Ham, M.

AU - Kuijpers, T.

AU - Rispens, T.

AU - Lowenberg, M.

AU - Eftimov, F.

PY - 2022/1

Y1 - 2022/1

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:000778573400068&DestLinkType=FullRecord&DestApp=WOS

M3 - Meeting Abstract

SN - 1873-9946

VL - 16

SP - I079-I079

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

ER -

Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! study

UN SDGs

Other files and links

Cite this